Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Nanoscale ; 15(16): 7384-7402, 2023 Apr 27.
Article in English | MEDLINE | ID: mdl-36751724

ABSTRACT

Magnetic nanoparticle (MNP) delivery systems are promising for targeted drug delivery, imaging, and chemo-hyperthermia of cancer; however, their uses remain limited primarily due to their toxicity associated with reactive oxygen species (ROS) generation, targeted delivery, and biodegradation. Attempts employing polymer coatings to minimize the toxicity, along with other challenges, have had limited success. We designed a novel yet generic 'one-for-all' polypropylene sulphide (PPS) coated magnetic nano-delivery system (80 ± 15 nm) as a multi-faceted approach for significant biocompatibility improvement, loading of multiple drugs, ROS-responsive delivery, and combined chemo-hyperthermia therapy for biomedical applications. Three distinct MNP systems (15 ± 1 nm) were fabricated, coated with PPS polymer, and investigated to validate our hypothesis and design. Simultaneous degradation of MNPs and PPS coatings with ROS-scavenging characteristics boosted the biocompatibility of MNPs 2-3 times towards non-cancerous fibroblasts (NIH3T3) and human epithelial cells (HEK293). In an alternating magnetic field, PPS-MNPs (MnFe) had the strongest heating characteristics (SAR value of 240 W g-1). PPS-MNP drug-loaded NPs were efficiently internalised into cells and released 80% of the drugs under tumor microenvironment-mimicking (pH 5-7, ROS) conditions, and demonstrated effective chemo-hyperthermia (45 °C) application for breast cancer cells with 95% cell death in combined treatment vs. 55% and 30% cell death in only hyperthermia and chemotherapy respectively.


Subject(s)
Hyperthermia, Induced , Magnetite Nanoparticles , Nanoparticles , Neoplasms , Animals , Mice , Humans , Polypropylenes/pharmacology , Magnetite Nanoparticles/therapeutic use , Reactive Oxygen Species , HEK293 Cells , NIH 3T3 Cells , Neoplasms/drug therapy , Neoplasms/metabolism , Drug Delivery Systems/methods , Hyperthermia, Induced/methods , Magnetic Phenomena , Tumor Microenvironment
2.
Appl Opt ; 59(12): 3652-3659, 2020 Apr 20.
Article in English | MEDLINE | ID: mdl-32400481

ABSTRACT

In this paper, a compact and broadband mode converter and demultiplexer based on multimode interference (MMI) is designed and experimentally demonstrated on silicon-on-insulator. We have designed a mode converter using cascaded MMI to convert the fundamental mode into a higher-order (first-order mode) and vice versa. Subsequently, we have demonstrated an on-chip two-mode demultiplexer with a compact footprint and low loss. The proposed mode demultiplexer shows low insertion loss (0.22 dB for ${{\rm TE}_0}$TE0 and 0.36 dB for ${{\rm TE}_1}$TE1 mode) and crosstalk (${-}{25.2}\;{\rm dB}$-25.2dB for ${{\rm TE}_0}$TE0 and ${-}{24.4}\;{\rm dB}$-24.4dB for ${{\rm TE}_1}$TE1 mode) at wavelength 1550 nm using the eigenmode expansion method. Moreover, the device supports a broad bandwidth having crosstalk ${ \lt } {-} {20}\;{\rm dB}$<-20dB over a wavelength range of 1520-1580 nm. The proposed device can be used in mode division multiplexing for photonic network-on-chip.

3.
Nanotechnology ; 31(45): 455604, 2020 Nov 06.
Article in English | MEDLINE | ID: mdl-32311684

ABSTRACT

The design and development of drug-delivery nanocarriers with high loading capacity, excellent biocompatibility, targeting ability and controllability have been the ultimate goal of the biomedical research community. In this work, we have reported the synthesis and characterization of novel and smart thermoresponsive polymer coated and Fe3O4 embedded hollow mesoporous silica (HmSiO2) based multifunctional superparamagnetic nanocarriers for the delivery of doxorubicin (Dox) for cancer treatment. P(NIPAM-MAm) coated and Fe3O4 nanoparticle (NP) embedded hollow mesoporous silica nanocomposite (HmSiO2-F-P(NIPAM-MAm)) was prepared by the in situ polymerization of NIPAM and MAm monomers on the surface of hollow mesoporous silica NPs (HmSiO2) in the presence of Fe3O4 NPs, oxidizer and crosslinker. TEM analysis showed nearly spherical morphology of HmSiO2-F-P(NIPAM-MAm) nanocarrier with a diameter in the range of 100-300 nm. The coating of P(NIPAM-MAm) layer and embedding of Fe3O4 NPs on the surface of the HmSiO2 NPs was revealed by HRTEM analysis. XRD and FTIR analysis also confirmed the presence of P(NIPAM-MAm) shells and Fe3O4 NPs on hollow mesoporous silica NPs. VSM analysis suggested the superparamagnetic nature of HmSiO2-F-P(NIPAM-MAm) nanocarrier. DSC analysis of HmSiO2-F-P(NIPAM-MAm) nanocarrier showed a phase transition at the temperature of ∼38 °C. The prepared HmSiO2-F-P(NIPAM-MAm) nanocarrier was investigated for its suitability for drug-delivery application using doxorubicin as the model drug by an in vitro method. The encapsulation efficiency and encapsulation capacity were found to be 95% and 6.8%, respectively. HmSiO2-F-P(NIPAM-MAm)-Dox has shown a pH and temperature-dependent Dox release profile. A relatively faster release of Dox from the nanocarrier was observed at temperature above the lower critical solution temperature (LCST) than below the LCST. HmSiO2-F-P(NIPAM-MAm) nanocarrier was found to be biocompatible in nature. In vitro cytotoxicity studies against Hela cells suggested that the HmSiO2-F-P(NIPAM-MAm)-Dox nanocomposite nanocarrier has good anticancer activity. In vitro cellular uptake study of HmSiO2-F-P(NIPAM-MAm)-Dox nanocomposite nanocarrier demonstrated its good internalisation ability into Hela cells. Thus, the prepared nanocomposites show potential as nanocarrier for targeted and controlled drug delivery for cancer treatment.


Subject(s)
Antibiotics, Antineoplastic/administration & dosage , Delayed-Action Preparations/chemistry , Doxorubicin/administration & dosage , Magnetic Iron Oxide Nanoparticles/chemistry , Silicon Dioxide/chemistry , Animals , Antibiotics, Antineoplastic/pharmacokinetics , Doxorubicin/pharmacokinetics , Drug Delivery Systems , Drug Liberation , HeLa Cells , Humans , Mice , Polymers/chemistry , RAW 264.7 Cells , Temperature
4.
Nanotechnology ; 28(36): 365101, 2017 Sep 08.
Article in English | MEDLINE | ID: mdl-28675377

ABSTRACT

In the present work, multifunctional Ni0.5Zn0.5Fe2O4@albumen (NZF@Alb) and doxorubicin-loaded Ni0.5Zn0.5Fe2O4@albumen (NZF@Alb-Dox) core-shell nanoparticles have been prepared by a green and simple method using inexpensive chicken egg albumen and have been characterized for different physiochemical properties. The structural, morphological, thermal, and magnetic properties of the prepared nanoparticles have been investigated by an x-ray diffractometer, high-resolution transmission electron microscopy (HRTEM), field emission scanning electron microscopy, Fourier-transformed infrared, thermogravimetric analysis, and vibrating sample magnetometer techniques. Superparamagnetic Ni0.5Zn0.5Fe2O4 nanoparticles (NZF NPs) with the mean size ∼20 nm were coated with albumen matrix by an ultrasonication process. Inverse fast Fourier transform-assisted HRTEM micrographs and FTIR analysis revealed the coating of amorphous albumen on crystalline NZF NPs. NZF@Alb and NZF@Alb-Dox NPs have the mean size (D50) of ∼100 nm, good stability, and magnetic controllability. Magnetic measurements (field (H)-dependent magnetization (M)) show all samples to be super-paramagnetic in nature. Biocompatibilities of the NZF and NZF@Alb NPs were confirmed by in vitro 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay against RAW 264.7 cells. NZF@Alb NPs have been found to be more biocompatible than bare NZF. In Vitro Dox release behavior from NZF@Alb-Dox NPs has been studied at pH 7.4 and 5, and a sustained and pH-dependent drug release profile were observed. In vitro cytotoxicity or anticancer activity of the blank NZF@Alb NPs, free Dox, and NZF@Alb-Dox NPs against HeLa cells (cancer cell line) were also examined by MTT assay. The obtained results suggest that this scalable egg-albumen-based magnetic nanoformulation is suitable for targeted drug delivery applications. Thus, the present study could be extremely useful for the advancement of albumin-based nanocarrier design and development for biomedical applications such as targeted and controlled delivery of anticancer drugs.


Subject(s)
Antibiotics, Antineoplastic/pharmacology , Delayed-Action Preparations/chemical synthesis , Doxorubicin/pharmacology , Drug Carriers/chemical synthesis , Magnetite Nanoparticles/chemistry , Albumins/chemistry , Animals , Antibiotics, Antineoplastic/chemistry , Cell Survival/drug effects , Delayed-Action Preparations/metabolism , Doxorubicin/chemistry , Drug Carriers/metabolism , Drug Compounding/methods , Drug Liberation , Ferric Compounds/chemistry , Green Chemistry Technology , HeLa Cells , Humans , Hydrogen-Ion Concentration , Kinetics , Magnetite Nanoparticles/ultrastructure , Mice , Nickel/chemistry , Particle Size , RAW 264.7 Cells , Zinc/chemistry
5.
Spectrochim Acta A Mol Biomol Spectrosc ; 137: 1348-56, 2015 Feb 25.
Article in English | MEDLINE | ID: mdl-25306130

ABSTRACT

A novel visible light active and magnetically separable nanophotocatalyst, Ni0.5Zn0.5Fe2O4/Zn0.95Ni0.05O (denoted as NZF@Z), with varying amount of Ni0.5Zn0.5Fe2O4, has been synthesized by egg albumen assisted sol gel technique. The structural, optical, magnetic, and photocatalytic properties have been studied by powder X-ray diffraction (XRD), transmission electron microscopy (TEM), field emission scanning electron microscopy (FESEM), fourier transform infrared spectroscopy (FTIR), UV-visible (UV-Vis) spectroscopy, and vibrating sample magnetometry (VSM) techniques. Powder XRD, TEM, FTIR and energy dispersive spectroscopic (EDS) analyses confirm coexistence of Ni0.5Zn0.5Fe2O4 and Zn0.95Ni0.05O phases in the catalyst. Crystallite sizes of Ni0.5Zn0.5Fe2O4 and Zn0.95Ni0.05O in pure phases and nanocomposites, estimated from Debye-Scherrer equation, are found to be around 15-25 nm. The estimated particle sizes from TEM and FESEM data are ∼(22±6) nm. The calculated energy band gaps, obtained by Tauc relation from UV-Vis absorption spectra, of Zn0.95Ni0.05O, 15%NZF@Z, 40%NZF@Z and 60%NZF@Z are 2.95, 2.72, 2.64, and 2.54 eV respectively. Magnetic measurements (field (H) dependent magnetization (M)) show all samples to be super-paramagnetic in nature and saturation magnetizations (Ms) decrease with decreasing ferrite content in the nanocomposites. These novel nanocomposites show excellent photocatalytic activities on Rhodamin Dye.


Subject(s)
Egg Proteins/chemistry , Ferric Compounds/chemistry , Nanocomposites/chemistry , Nickel/chemistry , Zinc Oxide/chemistry , Animals , Catalysis , Chickens , Fluorescent Dyes/chemistry , Fluorescent Dyes/isolation & purification , Light , Magnetic Phenomena , Magnets/chemistry , Nanocomposites/ultrastructure , Photolysis , Rhodamines/chemistry , Rhodamines/isolation & purification
6.
Spectrochim Acta A Mol Biomol Spectrosc ; 109: 313-21, 2013 May 15.
Article in English | MEDLINE | ID: mdl-23545437

ABSTRACT

In this study we have synthesized polyaniline/CoFe2O4 nanocomposites (PANI@CFs) by in situ polymerization method with different amounts of the CoFe2O4 nanoparticles NPs (CF-NPs) (0.5 g and 1.0 g). The structural optical, thermal and dielectric properties of the as synthesized PANI@CFs were studied. The XRD analysis ensures that CF-NPs have a single phase spinel structure. The XRD and EDAX results confirmed that the CF-NPs were successfully incorporated in the PANI matrix. The crystalline size analysis revealed that the size increased with increasing CF-NPs amount in the PANI@CFs, because of the aggregation effect. TGA exhibited an enhanced thermal stability of the PANI@CFs as compare with PANI owing to the strong interaction between the CF-NPs and polymer matrix. The energy band gaps as calculated through the Tauc relation were found to be gradually higher with the increasing the amount of CF-NPs in PANI@CFs. The dielectric constants (ε', ε″), dielectric loss (tanδ) and AC conductivity (σac) were studied as the function of frequency and composition, which have been explained by 'Maxwell Wagner Model'. The high dielectric constant and ac conductivity were observed of PANI@CFs than PANI. Moreover, PANI@CF 1:2 exhibited the promising photocatalytic activity for the photo-decoloration of the methyl orange (MO) dye under UV light irradiation. Results also showed protection of photo-decoloration of the MO dye by the disodium ethylenediaminetetraacetate dehydrate (EDTA-Na2; C10H14N2Na2O8·2H2O) (hole scavenger) and tert-butyl alcohol (C4H10O) (radical scavenger) clearly suggested the implication of reactive oxygen species (ROS) in the photocatalytic activity of PANI@CF 1:2. It is encouraging to conclude that PANI@CF bears the potential of its applications in photocatalysis.


Subject(s)
Aniline Compounds/chemistry , Cobalt/chemistry , Ferric Compounds/chemistry , Nanocomposites/chemistry , Aniline Compounds/chemical synthesis , Azo Compounds/chemistry , Catalysis , Ferric Compounds/chemical synthesis , Nanocomposites/ultrastructure , Nanoparticles/chemistry , Nanoparticles/ultrastructure , Nanotechnology , Photolysis , Polymerization , Powder Diffraction , Surface Properties , Ultraviolet Rays , X-Ray Diffraction
SELECTION OF CITATIONS
SEARCH DETAIL
...